Analysis by GenericsWeb Reveals More Than a Third of Granted or Pending SPCs are Potentially Invalid
Following the recent Medeva rulings, GenericsWeb, the leader in established pharmaceutical patent analysis and searching, decided to verify every SPC to determine their potential invalidity. The result of this analysis is that more than a third of granted or pending SPCs have questionable validity on the basis of these recent rulings. Sydney, Australia (PRWEB) June 27, 2012 After the recent decisions handed down by the Court of Justice of the European Union (CJEU) in Medeva (C 322/10) and the related Georgetown (C-422/10), Queensland (C-630/10), Yeda (C 518/10) and Daiichi (C-6/11) referra
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 313
- Bankruptcy 44
- Business 135
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 58
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4